Clinical Trial Update: The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting

View source ↗

Summary

This clinical trial update examines the real-world epidemiology of patients treated with the atezolizumab and bevacizumab combination for hepatocellular carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (Tecentriq) (atezolizumab)
• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | Conditions: Hepatocellular Carcinoma (HCC) | Status: NOT_YET_RECRUITING